# SDC for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation

> **NCT01855191** · — · COMPLETED · sponsor: **Maastricht Radiation Oncology** · enrollment: 864 (actual)

## Conditions studied

- Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01855191
- **Lead sponsor:** Maastricht Radiation Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2019-02
- **Final completion:** 2019-02
- **Target enrollment:** 864 (ACTUAL)
- **Last updated:** 2019-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01855191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01855191, "SDC for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01855191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*